Cargando…
Dual Antiplatelet Therapy vs. Single Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: An Updated Systematic Review and Meta-Analysis
Background: Although mainstream guidelines recommend dual antiplatelet therapy (DAPT) with aspirin and clopidogrel in patients following transcatheter aortic valve replacement (TAVR), it is not evidence-based. We aim to investigate the safety and efficacy of DAPT vs. single antiplatelet therapy (SAP...
Autores principales: | Zhang, Yipeng, Shen, Lan, Yang, Wentao, He, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255616/ https://www.ncbi.nlm.nih.gov/pubmed/34235187 http://dx.doi.org/10.3389/fcvm.2021.679703 |
Ejemplares similares
-
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
por: Park, Hanbit, et al.
Publicado: (2021) -
Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022) -
Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
por: Valvo, Roberto, et al.
Publicado: (2019) -
Update on Transcatheter Tricuspid Valve Replacement Therapies
por: Goldberg, Ythan H., et al.
Publicado: (2021) -
Procedural outcomes in patients with dual versus single antiplatelet therapy prior to transcatheter aortic valve replacement
por: Seoudy, Hatim, et al.
Publicado: (2021)